Beijing Hanshi United

Beijing Hanshi United Biotechnology Co., Ltd. was founded in 2007. With cell regenerative medicine technology as its core, the company focuses on innovation and development in the cell technology industry. It has established four major industrial sectors: Han's Biology, Han's Pharmaceutical, Han's Medical, and Sino神州, covering cell storage and preparation, clinical research of cells, new drug development, medical industry, health management, precision testing, biological skincare, health tourism, CDMO technical services, and the International Cell Valley. The goal is to build a complete closed-loop of the regenerative medicine industry chain. Han's Biology provides perinatal cell storage and adult immune cell storage services, CDMO technical services, biological testing services, and new drug evaluation services. It has established 7 cell banks nationwide, along with several nationally accredited testing and safety evaluation centers, provincial engineering research centers, CNAS laboratories, and product R&D and manufacturing centers. It has cooperated with dozens of research institutions and medical institutions, providing CDMO technical services, successfully assisting multiple stem cell clinical research institutions in completing dual filings, and promoting the innovation and industrial development of cell technology. Han's Pharmaceutical, with cell regenerative medicine at its core, is committed to the clinical application and commercial development of cell drugs and biological products, making affordable cell drugs for the public. Currently, the pharmaceutical sector has four cell new drug R&D platforms located in Tianjin, Beijing, Jiangxi, and France, independently developing various dosage forms. Several IND applications for stem cell class 1 new drugs have been approved and are undergoing clinical trials. It is a leader in the domestic field of cell new drug R&D and will become an international pioneer in cell technology in the future. Han's Medical is a comprehensive service platform integrating medical treatment, health care, scientific research, prevention, physical examination, and medical aesthetics. It is characterized by clinical translational research of cell therapy, utilizing precision regenerative medicine and smart medical means, adhering to goals such as early diagnosis, early intervention, precision medicine, and full-life-cycle health management, providing high-quality medical and health services to local and international patients. Sino神州 is a technology-oriented enterprise focusing on life health management and customized solutions, beauty and anti-aging products, research and sales, and operation of a large health industry park. It is committed to the engineering, process, and standardization of cutting-edge biotechnology to achieve large-scale industrialization and standardized application, extending to the health industry for disease prevention and treatment, providing terminal users with a direct, efficient, and face-to-face scientific service platform. Cells carry hope; technology fulfills dreams. Over the past decade, Han's United has been dedicated to the industrialization of cell technology, realizing the health dream of benefiting all humanity. In the future, Han's United will continue to focus on cell regenerative medicine technology, develop around the four major sectors, create a national brand combining "production, education, research, medical care, wellness, and beauty," establish a strong cell technology brand at home and abroad, lead the regenerative medicine industry, and provide people with high-quality medical and health services. We sincerely invite like-minded individuals to join our team and contribute to human health and China's stem cell industry.